The ENA virtual meeting 2020
Published: 4 Nov 2020
Views: 213
Dr. Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
Dr Toni Choueiri speaks to ecancer about the important highlights of this year’s ENA virtual meeting and how they can impact cancer research in the future.
He speaks about a few upcoming clinical trials that can play a pivotal role in translational medicine and winds it up by thanking the organisers for a successful, informative meeting.
Related Videos
Promise of personalised medicine for patients with prostate cancer
Prof Eleni Efstathiou, Prof Alicia Morgans, Prof Karim Fizazi and Prof Gerhardt ...
26 Feb 2021
The use of PARP inhibitors in oncology from a palliative care perspective
Judy Knudson, PA-C - University of Colorado, Denver, USA
24 Dec 2020
Five year update of ECHELON-1 for classical Hodgkin lymphoma
Dr Otavio Baiocchi - Centro Especializado em Oncologia, São Paulo, Brazil
8 Dec 2020
Real world management of multiple myeloma patients
Dr Patricio Duarte - Instituto Universitario CEMIC, Buenos Aires, Argentina
8 Dec 2020
ESMO 2020 melanoma roundup
Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany
28 Sep 2020
PARP inhibitors and their evolving role for the treatment of prostate cancer
Dr Neal Shore, Dr Neeraj Agarwal, Dr Elena Castro and Dr Kim Chi
24 Sep 2020
CD-19 mutation frequency after blinatumomab treatment is lower than after CAR T-...
Dr Michaela Kotrova - Universitätsklinikum Schleswig-Holstein, Kiel, Germany
20 Jun 2019
The changing landscape of AML
Prof Torsten Haferlach - MLL Münchner Leukämielabor GmbH, Munich, Germany
20 Jun 2019
Cutting-edge cancer care at the Miami Cancer Institute
Dr Miguel Villalona - Miami Cancer Institute, Miami, USA
18 Jun 2019
